Evidence map›Paper›PMID 37311823›Full record

Trial reportHeart and vessels2023

Changes in CHA

Eirinaios Tsiartas, Athanasios Samaras, Andreas S Papazoglou, Anastasios Kartas, Dimitrios V Moysidis, Eleftherios Gemousakakis, Odysseas Kamzolas, Alexandra Bekiaridou, Ioannis Doundoulakis, Apostolos Tzikas and 1 more

Registry-linked trialOpen access · hybridAbstract readRandomized Controlled TrialObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Heart and vessels, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02941978 (Motivational Interviewing to Support Oral AntiCoagulation Adherence in Patients With Non-valvular Atrial Fibrillation), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02941978 nacompletednot on this map

Motivational Interviewing to Support Oral AntiCoagulation Adherence in Patients With Non-valvular Atrial Fibrillation (MISOAC-AF): A Prospective Randomized Clinical Study

TypeinterventionalSponsorAHEPA University HospitalRan2015 to 2019Enrolled1,140ConditionsPatient Compliance, Patient AdherenceArmsMotivational interview, Control
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Observational
  2. Timing of stroke risk reassessment in atrial fibrillation patients with a CHA2DS2-VA score of 0 or 1: the Norwegian AFNOR study.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Eirinaios TsiartasFirst Cardiology Department, School of Medicine, Faculty of Health Sciences, AHEPA University Hospital, Aristotle University of Thessaloniki, 1 Kiriakidi, Thessaloniki, 546 36, Greece.
Athanasios SamarasFirst Cardiology Department, School of Medicine, Faculty of Health Sciences, AHEPA University Hospital, Aristotle University of Thessaloniki, 1 Kiriakidi, Thessaloniki, 546 36, Greece.
Andreas S PapazoglouFirst Cardiology Department, School of Medicine, Faculty of Health Sciences, AHEPA University Hospital, Aristotle University of Thessaloniki, 1 Kiriakidi, Thessaloniki, 546 36, Greece.
Anastasios KartasFirst Cardiology Department, School of Medicine, Faculty of Health Sciences, AHEPA University Hospital, Aristotle University of Thessaloniki, 1 Kiriakidi, Thessaloniki, 546 36, Greece.
Dimitrios V MoysidisFirst Cardiology Department, School of Medicine, Faculty of Health Sciences, AHEPA University Hospital, Aristotle University of Thessaloniki, 1 Kiriakidi, Thessaloniki, 546 36, Greece.
Eleftherios GemousakakisFirst Cardiology Department, School of Medicine, Faculty of Health Sciences, AHEPA University Hospital, Aristotle University of Thessaloniki, 1 Kiriakidi, Thessaloniki, 546 36, Greece.
Odysseas KamzolasFirst Cardiology Department, School of Medicine, Faculty of Health Sciences, AHEPA University Hospital, Aristotle University of Thessaloniki, 1 Kiriakidi, Thessaloniki, 546 36, Greece.
Alexandra BekiaridouFirst Cardiology Department, School of Medicine, Faculty of Health Sciences, AHEPA University Hospital, Aristotle University of Thessaloniki, 1 Kiriakidi, Thessaloniki, 546 36, Greece.
Ioannis DoundoulakisFirst Cardiology Department, School of Medicine, Faculty of Health Sciences, AHEPA University Hospital, Aristotle University of Thessaloniki, 1 Kiriakidi, Thessaloniki, 546 36, Greece.
Apostolos TzikasFirst Cardiology Department, School of Medicine, Faculty of Health Sciences, AHEPA University Hospital, Aristotle University of Thessaloniki, 1 Kiriakidi, Thessaloniki, 546 36, Greece.
George GiannakoulasFirst Cardiology Department, School of Medicine, Faculty of Health Sciences, AHEPA University Hospital, Aristotle University of Thessaloniki, 1 Kiriakidi, Thessaloniki, 546 36, Greece. g.giannakoulas@gmail.com.
Aristotle University of Thessaloniki · GRAHEPA University Hospital · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsThe CHA MATERIALS AND

methodsThis is an observational analysis of 1127 atrial fibrillation patients previously enrolled in the MISOAC-AF trial. After a median 2.6-year follow-up period, baseline and follow-up CHA

resultsThe mean baseline, follow-up, and Delta CHA

conclusionIn atrial fibrillation patients, changes in CHA

trial registrationThis is an observational, post-hoc analysis of the MISOAC-AF randomized controlled trial, registered on ClinicalTrials.gov (identifier: NCT02941978; registered: October 21, 2016).

Indexed as

Atrial FibrillationIschemic StrokeStrokeHumansRisk AssessmentRisk FactorsAtrial fibrillationCHA2DS2-VASc scoreIschemic strokeOral anticoagulationStroke risk

Identifiers

PMID37311823
PMCPMC10465382
OpenAlexW4380479795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.